Officers / Committee

President

• 

  Makoto Kobayashi, MEng, PhD

  COO
  CRECON MEDICAL ASSESSMENT INC.
  Tokyo, Japan

President-elect

• 

  Rei Goto, MD, PhD

  Professor
  Keio University
  Kanagawa, Japan

Past President

• 

  Shinichi Noto, MS, PhD

  Niigata University of Health and Welfare
  Center for Health Economics & QOL Research
  Niigata, Japan
  CHEERS: Comprehensive Unit for Health Economic Evidence Review and Decision Support,
  Ritsumeikan University
  Kyoto, Japan

Councilors

• 

  Tomohide Akase, PhD, MBA

  Professor
  Japan University of Economics, Graduate School of Business
  Tokyo, Japan

• 

  Toshihiko Aranishi, Ph.D

  HTA Director
  Eli Lilly Japan K.K.
  Kobe, Japan

• 

  Ataru Inagaki, MD, DrMedSci

  Professor
  Aoyama Gakuin University
  Tokyo, Japan

• 

  Miyuki Ezura, MS

  Associate Professor
  Keio University
  Pharmacoeconomics, Corporate Planning Dept.
  Otsuka Holdings Co., Ltd.
  Tokyo, Japan

• 

  Shinya Ohno, Ph.D., MPH

  Director
  Medical Affairs Div.
  Chugai Pharmaceutical Co., Ltd.
  Tokyo, Japan

• 

  Koji Kawakami, MD, PhD

  Professor and Chair
  Kyoto University
  Kyoto, Japan

• 

  Mitsuhiro Sado, M.D., M.Sc., Ph.D.

  Professor
  Health Center
  Keio University
  Tokyo, Japan

• 

  Yurie Taguchi, PhD, MBA, MA

  Johnson & Johnson Family of Companies in Japan

• 

  Tomoyuki Takura,PhD

  Chief Professor
  Nihon University of School of Medicine
  Division of Health Care Service Management
  Project Professor
  Department of Healthcare economics and Health Policy,
  Tokyo University,
  Graduate school of Medicine/Faculty of Medicine
  Tokyo, Japan

• 

  Makoto Tamura, Ph.D.

  CEO / Founder
  Healthcare System Planning Institute
  Tokyo, Japan

• 

  Shuichi Yamaguchi

  Center for Outcomes Research and Economic Evaluation for Health (C2H),
  National Institute of Public Health
  Saitama, Japan

Executive Committee Members

• 

  Manabu Akazawa, PhD, MPH

  Professor
  Meiji Pharmaceutical University
  Tokyo, Japan

• 

  Mie Azuma（nee, Kasai) PhD (HEcon), RPharm

  Associate director
  Eisai Co., Ltd.
  Tokyo, Japan

• 

  Ataru Igarashi, PhD

  Visiting Associate Professor
  Dept. of Health Economics and Outcomes Research,
  Graduate School of Pharmaceutical Sciences,
  The University of Tokyo
  Associate Professor
  Unit of Public Health and Preventive Medicine,
  Yokohama City University School of Medicine.
  Tokyo, Japan

• 

  Shunya Ikeda, MD, PhD

  Professor of Public Health
  School of Medicine
  International University of Health and Welfare
  Narita, Japan

• 

  Shinya Saito, MD, PhD

  President
  Okayama Healthcare Professional University
  Okayama, Japan

• 

  Takeru Shiroiwa, MPH, PhD

  Chief Senior Researcher
  Center for Outcomes Research and Economic Evaluation for Health (C2H),
  National Institute of Public Health
  Saitama, Japan

• 

  Naohiro Nakahara, PhD

  Zimmer Biomet G.K.
  Tokyo, Japan

• 

  Takashi Fukuda, PhD

  Director
  Center for Outcomes Research and Economic Evaluation for Health (C2H),
  National Institute of Public Health
  Saitama, Japan

• 

  Kensuke Moriwakii, MSc, PhD

  Associate Professor
  Laboratory of Health Policy and Management, Department of Biomedical Sciences, College of Life Sciences,
  Ritsumeikan University
  Shiga, Japan
  CHEERS: Comprehensive Unit for Health Economic Evidence Review and Decision Support,
  Ritsumeikan University
  Kyoto, Japan

Auditors

• 

  Haku Ishida, MD, PhD

  Professor
  Department of Medical Informatics and Decision Sciences
  Yamaguchi University
  Yamaguchi, Japan

• 

  Shinichiro Yanagisawa, PhD

  Professor
  Himeji Dokkyo University
  Hyogo, Japan

Secretary

• 

  Takeru Shiroiwa, MPH, PhD

  Chief Senior Researcher
  Center for Outcomes Research and Economic Evaluation for Health (C2H),
  National Institute of Public Health
  Saitama, Japan